share_log

Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target

Benzinga ·  Feb 6 00:19

Cantor Fitzgerald analyst Louise Chen reiterates Merck & Co (NYSE:MRK) with a Overweight and maintains $135 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment